Ecuador authorises Wandercraft Atalante X for clinical rehabilitation
Ecuador’s ARCSA authorised the Atalante X self-balancing rehabilitation exoskeleton for specified neurological rehabilitation uses, with the first announced installation at Clínica de Lesiones Deportivas in Quito.
Evidence notes
- The authorised uses cover rehabilitation associated with spinal-cord injury, stroke-related hemiplegia and multiple sclerosis.
- Clínica de Lesiones Deportivas in Quito is the first announced Ecuador installation site.
- The clinic describes Atalante X as forthcoming in 2026; authorisation is not represented as an already operating installation.
Company context
Develops self-balancing robotic exoskeletons designed to restore walking ability for people with mobility impairments. The systems use dynamic stabilization to enable hands-free locomotion without crutches or walkers.